SpectraScience: Innovations in Cancer Detection
SpectraScience has developed patented platform technology that diagnoses colorectal cancer, which has a market size of $1, 442.6 million.
SpectraScience has developed patented platform technology that diagnoses colorectal cancer, which has a market size of $1, 442.6 million.
BioLife Solutions has a strong interest in target markets: regenerative medicine, biobanking, and drug discovery.
Orexigen Therapeutics is a biopharmaceutical company that focuses its attention on the treatment of one of the most common diseases in existence today, obesity.
With OneMedForumNY 2013 just one month away (and a few healthcare conferences coming up), we thought it best to step away from our usual editorial functions and instead offer a ‘how to’ on enhancing your conference experience. Below, find 10 (actually, 11) tips to maximizing your conference networking. We’ve scattered in some special tricks, as well.
In response to a recent press release from TONIX Pharmaceuticals, a leading company in the exploration of alternative PTSD treatment, we are issuing a 2-part special report looking at recent developments
Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.
Electro-Optical Sciences (EOS), an Irvington, NY-based company that’s working on a device for diagnosing melanoma, has raised $11.5 million in a private placement. The money […]
A July 31 CNET.com column says medical devices may be the answer for job seekers who, despite a fascination with medicine, are disenchanted with the […]
ev3, a Plymouth, MN-based endovascular device firm, has received CE Mark approval for a new product that treats cerebral aneurysm. The Axium Detachable Coil System […]
Copyright © 2024 | WordPress Theme by MH Themes